Knockdown of HOP in glioma cells reduced proliferation rate and invasion through alteration to the protein kinase B or serine/threonine kinase 1 (AKT)/tumor necrosis factor receptor protein 1 (TRAP1) signaling pathway (77). This evidence concerns the gene AKT1 and central nervous system cancer.